NetworkNewsBreaks

ThursdayFeb 29, 2024 1:38 pm

NetworkNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Capitalizing on Growing Transition to Renewables

Turbo Energy (NASDAQ: TURB), a designer, developer and manufacturer of photovoltaic energy generation, management and storage equipment, has sought to take advantage of the dramatic increase in renewable energy demand, which has been driven by the decline in renewable energy costs and the exponential rise in fossil fuel prices. “Turbo Energy has looked to capitalize on the growing transition toward renewable energy and sustainable residential energy supplies through its revolutionary ‘SunBox Home’ energy storage solution. The company’s ‘SunBox Home’ system encompasses an all-in-one AI-powered energy storage solution, designed to assist households in managing their power consumption. Directly linked to a…

Continue Reading

ThursdayFeb 29, 2024 1:20 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Welcomes Second Native American Tribal Customer

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, today announced that the Oglala Lakota Nation is adopting the SOBRcheck(TM) technology for use in its community-wide probation management program. The Oglala Lakota Nation is a self-governing nation within the U.S., and its Pine River Reservation in South Dakota is the eighth-largest Native American reservation in the country. “Our law enforcement function is resource-constrained, so we are always seeking ways to innovate and gain operational efficiencies,” said Warren Cross, lab director, Oglala Sioux Tribe Clinical Lab. “SOBRcheck is faster and cleaner than the legacy breathalyzer method, both…

Continue Reading

ThursdayFeb 29, 2024 10:19 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN), Subsidiary Report Positive Clinical Results of CNM-Au8 Treatment at MS Forum

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., is reporting on the full clinical results for CNM-Au8(R), an investigational first-in-class therapy designed to improve central nervous system cells’ survival and function. Clene, which is focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), presented the results at the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum in Florida. The results were gathered from the VISIONARY-MS trial long-term open label extension (“LTE”) in participants with stable…

Continue Reading

ThursdayFeb 29, 2024 10:00 am

NetworkNewsBreaks – Ocean Biomedical Inc.’s (NASDAQ: OCEA) Joint Venture Partner to Present First Clinical Study Data at 33rd Annual Meeting of APASL

Ocean Biomedical (NASDAQ: OCEA), a biopharma company that endeavors to accelerate the development of compelling discoveries from top research scientists, congratulates its joint venture partner, Virion Therapeutics, LLC, a clinical-stage biotechnology company developing T cell-based immunotherapies, for the acceptance of its abstract highlighting the first-ever human data from its novel checkpoint modifier immunotherapy for HBV functional cure. The abstract was accepted for late breaker oral presentation at the 33rd Annual Meeting of APASL (The Asian Pacific Association for the Study of the Liver), taking place in Kyoto, Japan, from March 27-31, 2024. “This accepted abstract highlights Virion’s commitment to finding…

Continue Reading

ThursdayFeb 29, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Participate at Upcoming Sixth International Congress on Controversies in Fibromyalgia

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, will be featured at the upcoming Sixth International Congress on Controversies in Fibromyalgia. The event is scheduled for March 7, 2024, in Brussels, Belgium. During the one-day event, Tonix Pharmaceuticals CEO Seth Lederman, MD, is slated to present. During his presentation, Lederman will provide an overview of data from the recently reported positive phase 3 RESILIENT trial of Tonmya(TM) (also known as TNX-102 SL) for the management of fibromyalgia. To view the full press release, visit https://nnw.fm/s110j About Tonix Pharmaceuticals Holding Corp. Tonix is…

Continue Reading

WednesdayFeb 28, 2024 3:33 pm

NetworkNewsBreaks – GEMXX Corp. (GEMZ) Leveraging Competitive Advantage with Mine-to-Market Business Model

GEMXX (OTC: GEMZ) is a company that focuses not only on producing gold, gemstone and jewelry from its own land resources, production facilities and operating assets but also on global distribution. “With the company controlling all of these stages as part of its strategy to support its mine-to-market business model, GEMXX has established a significant competitive advantage. As a McKinsey report details: ‘The mining value chain – which includes everything from extracting raw material to delivering products to consumers – is the backbone of the industry. Companies that manage their value chain well can establish a significant source of competitive…

Continue Reading

WednesdayFeb 28, 2024 2:59 pm

NetworkNewsBreaks – Acri Capital Acquisition Corporation (NASDAQ: ACACU), Foxx Development Inc. Enter Business Combination Agreement

Acri Capital (NASDAQ: ACAC, ACACU, ACACW), a Delaware incorporated special purpose acquisition company listed on the Nasdaq Global Market, and Foxx Development Inc., a Texas-based consumer electronics and integrated Internet-of-Things (“IoT”) solution company, have announced their entry into a definitive business combination agreement. Under the agreement, a newly established subsidiary of Acri will become a publicly listed company combining Acri and Foxx (the “combined company”) upon the closing of the transaction, with expected listing of its common stock on the Nasdaq. “Acri’s inception revolved around the goal of identifying and partnering with companies led by visionary, mission-oriented leadership teams who…

Continue Reading

WednesdayFeb 28, 2024 2:49 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Announces Strategic Appointment of Garrett Gardi

HealthLynked (OTCQB: HLYK), a leader in health care technology solutions for patients and providers, has announced the addition of Garrett Gardi to its advisory board. Gardi has more than two decades of experience in employee benefit plans, specializing in predictive cost analytics, consumer-driven platforms, and self-funded/alternative funding methodologies, and brings a wealth of knowledge and expertise to the HealthLynked team. “Garrett’s addition to our advisory board marks a significant milestone for HealthLynked as we continue to expand our reach and impact in the health care sector,” said Dr. Michael Dent, CEO of HealthLynked. “His extensive experience and innovative approach to…

Continue Reading

WednesdayFeb 28, 2024 2:38 pm

NetworkNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Columbia-Based Subsidiary Names Agri-Tech Leader as Sales Director

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced that Eko2o S.A.S., a majority controlled subsidiary of MedCana in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, has appointed Paula Restrepo as its new sales director. With a career spanning over nine years as a technical representative for a prominent technology company in the Colombian flower industry, Restrepo brings a wealth of experience and a fresh perspective to the EKO2O team. Restrepo’s extensive background in agricultural technology and deep understanding of the Colombian market make her an invaluable asset. “We are thrilled to welcome Paula Restrepo to…

Continue Reading

WednesdayFeb 28, 2024 2:21 pm

NetworkNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Announces New Starter Course for Quantum Computing Programmers

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, has unveiled a six-module quantum training course designed for beginner quantum programmers. Called “Foundations for Quantum Programming,” the self-paced, online course teaches essential mathematics and Python skills and prepares individuals to continue on to successfully take D-Wave’s flagship course, “Quantum Programming Core.” The course includes video presentations, quizzes and hands-on programming activities that will assist students in learning to identify optimization problem objectives and variables, represent problem objectives as mathematical expressions, convert constraints to penalty functions…

Continue Reading